The online version of this article (doi:10.1186/1477-7819-10-25) contains supplementary material, which is available to authorized users.
Eric LR Bédard and Daniel Schiller contributed equally to this work.
The authors declare that they have no competing interests.
RSG: Participated in study design, data collection and analysis. Writing manuscript and revisions. Approved final version of manuscript.
TP: Participated in study design and data collection. Writing manuscript and revisions. Approved final version of manuscript.
JTA: Creation of figures. Writing and revising manuscript. Approved final version of manuscript.
ELRB: Study design and analysis. Revising manuscript. Approved final version of manuscript.
DS: Study design and analysis. Revising manuscript. Approved final version of manuscript.
Lung cancer is a common cause of cancer-related death. Staging typically includes positron emission tomography (PET) scanning, in which18F-fluoro-2-dexoy-D-glucose (FDG) is taken up by cells proportional to metabolic activity, thus aiding in differentiating benign and malignant pulmonary nodules. Uptake of FDG can also occur in the abdomen. The clinical significance of incidental intraabdominal FDG uptake in the setting of pulmonary nodules is not well established. Our objective was to report on the clinical significance of incidental intra-abdominal FDG activity in the setting of lung cancer.
Fifteen hundred FDG-PET reports for studies performed for lung cancer were retrospectively reviewed for the presence of incidental FDG-positive intraabdominal findings. Patient charts with positive findings were then reviewed and information extracted.
Twenty-five patients (25/1500) demonstrated incidental intraabdominal FDG uptake thought to be significant (1.7%) with a mean patient age of 71 years. Colonic uptake was most common (n = 17) with 9 (52%) being investigated further. Of these 9 cases, a diagnosis of malignancy was made in 3 patients, pre-malignant adenomas in 2 patients, a benign lipoma in 1 patient and no abnormal findings in the remaining patients. 8 patients were not investigated further (3 diagnosed with metastatic lung cancer and 2 were of advanced age) secondary to poor prognosis.
Incidental abdominal findings in the colon on FDG-PET scan for work-up of pulmonary nodules need to be further investigated by colonoscopy.
Reed CE, Harpole DH, Posther KE, Woolson SL, Downey RJ, Meyers BF, Heelan RT, MacApinlac HA, Jung SH, Silvestri GA, Siegel BA, Rusch VW: Results of the American college of surgeons oncology group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003, 126: 1943-1951. 10.1016/j.jtcvs.2003.07.030. CrossRefPubMed
Ido T, Wan C, Carella V, Fowler JS, Wolf AP, Reivich M, Kuhl DE: Labeled 2-deoxy-D-glucose analogs: 18F-labeled 2-deoxy-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-mannose and 14C-2-deoxy-2-fluoro-D-glucose. J Label Compds Radiopharm. 1978, 24: 174-83.
Giovannucci E: An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2001, 10: 725-731. PubMed
Lee ST, Tan T, Poon AMT, Toh HB, Gill S, Berlangieri SU, Kraft E, Byrne AJ, Pathmaraj K, O'Keefe GJ, Tebbutt N, Scott AM: Role of low-dose, noncontrast computed tomography from integrated positron emission tomography/computed tomography in evaluating incidental 2-deoxy-2-[F-18]fluro-D-glucose-avid colon lesions. Mol Imaging Biol. 2008, 10: 48-53. 10.1007/s11307-007-0117-0. CrossRefPubMed
- The clinical significance of incidental intra-abdominal findings on positron emission tomography performed to investigate pulmonary nodules
Richdeep S Gill
Jonathan T Abele
Eric LR Bédard
- BioMed Central
Neu im Fachgebiet Chirurgie
e.Med Kampagnen-Visual, Mail Icon II